A Double-Blind Placebo-Controlled Study of Lamotrigine Monotherapy in Outpatients With Bipolar I Depression
The DOI matches its Crossref record.
Abstract
BACKGROUND: More treatment options for bipolar depression are needed. Currently available antidepressants may increase the risk of mania and rapid cycling, and mood stabilizers appear to be less effective in treating depression than mania. Preliminary data suggest that lamotrigine, an established antiepileptic drug, may be effective for both the depression and mania associated with bipolar disorder. This is the first controlled multicenter study evaluating lamotrigine monotherapy in the treatment of bipolar I depression. METHODS: Outpatients with bipolar I disorder experiencing a major depressive episode (DSM-IV, N = 195) received lamotrigine (50 or 200 mg/day) or placebo as monotherapy for 7 weeks. Psychiatric evaluations, including the Hamilton Rating Scale for Depression (HAM-D), the Montgomery-Asberg Depression Rating Scale (MADRS), Mania Rating Scale, and the Clinical Global Impressions scale for Severity (CGI-S) and Improvement (CGI-I) were completed at each weekly visit. RESULTS: Lamotrigine 200 mg/day demonstrated significant antidepressant efficacy on the 17-item HAM-D, HAM-D Item 1, MADRS, CGI-S, and CGI-I compared with placebo. Improvements were seen as early as week 3. Lamotrigine 50 mg/day also demonstrated efficacy compared with placebo on several measures. The proportions of patients exhibiting a response on CGI-I were 51%, 41%, and 26% for lamotrigine 200 mg/day, lamotrigine 50 mg/day, and placebo groups, respectively. Adverse events and other safety results were similar across treatment groups, except for a higher rate of headache in the lamotrigine groups. CONCLUSION: Lamotrigine monotherapy is an effective and well-tolerated treatment for bipolar depression.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“while clinical experience and the results of many studies suggest that response to mood stabilizers and antipsychotics is similar in BDII and BDI, there are enough exceptions to suggest this should not be taken for granted.248, 405, 431”
Citations
Cites
Still being checked.
Cited by
A randomized trial of an N-methyl-D-aspartate antagonist in treatment-resistant major depression.
Zarate, C. A., Singh, J. B., Carlson, P. J., Brutsche, N. E., Ameli, R., Luckenbaugh, D. A., Charney, D. S., & Manji, H. K. (2006) · Archives of General Psychiatry · doi:10.1001/archpsyc.63.8.856 · Cited by 3,766
Yatham, L. N., Kennedy, S. H., Parikh, S. V., Schaffer, A., Bond, D. J., Frey, B. N., Sharma, V., Goldstein, B. I., Rej, S., Beaulieu, S., et al. (2018) · Bipolar Disorders · doi:10.1111/bdi.12609 · Cited by 1,852
Self-citationGoodwin, G., Haddad, P., Ferrier, I., Aronson, J., Barnes, T., Cipriani, A., Coghill, D., Fazel, S., Geddes, Jr., Grunze, H., et al. (2016) · Journal of Psychopharmacology · doi:10.1177/0269881116636545 · Cited by 1,309
Yatham, L. N., Kennedy, S. H., Parikh, S. V., Schaffer, A., Beaulieu, S., Alda, M., O’Donovan, C., MacQueen, G., McIntyre, R. S., Sharma, V., et al. (2013) · Bipolar Disorders · doi:10.1111/bdi.12025 · Cited by 1,217
Tohen, M., Vieta, E., Calabrese, J., Ketter, T. A., Sachs, G., Bowden, C., Mitchell, P. B., Centorrino, F., Risser, R., Baker, R. W., et al. (2003) · Archives of General Psychiatry · doi:10.1001/archpsyc.60.11.1079 · Cited by 908
Self-citationCalabrese, J. R., Keck, P. E., Macfadden, W., Minkwitz, M., Ketter, T. A., Weisler, R. H., Cutler, A. J., McCoy, R., Wilson, E., Mullen, J., et al. (2005) · American Journal of Psychiatry · doi:10.1176/appi.ajp.162.7.1351 · Cited by 883
Self-citationWhat Is a “Mood Stabilizer”? An Evidence-Based Response
Bauer, M. S., & Mitchner, L. (2004) · American Journal of Psychiatry · doi:10.1176/appi.ajp.161.1.3 · Cited by 862
Rush, A. J., George, M. S., Sackeim, H. A., Marangell, L. B., Husain, M. M., Giller, C., Nahas, Z., Haines, S., Simpson, R. K., & Goodman, R. (2000) · Biological Psychiatry · doi:10.1016/s0006-3223(99)00304-2 · Cited by 688
Bowden, C. L. (2003) · Archives of General Psychiatry · doi:10.1001/archpsyc.60.4.392 · Cited by 658
Self-citationPractice Guideline for the Treatment of Patients With Bipolar Disorder (Revision)
Hirschfeld, R. M. A., Bowden, C. L., Gitlin, M. J., Keck, P. E., Perlis, R. H., Suppes, T., Thase, M. E., & Wagner, K. D. (2003) · Focus · doi:10.1176/foc.1.1.64 · Cited by 585
Self-citationSackeim, H. (2001) · Neuropsychopharmacology · doi:10.1016/s0893-133x(01)00271-8 · Cited by 568
Millan, M. J. (2006) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2005.11.006 · Cited by 551
Antidepressants for Bipolar Depression: A Systematic Review of Randomized, Controlled Trials
Gijsman, H. J., Geddes, J. R., Rendell, J. M., Nolen, W. A., & Goodwin, G. M. (2004) · American Journal of Psychiatry · doi:10.1176/appi.ajp.161.9.1537 · Cited by 563
Yatham, L. N., Kennedy, S. H., Schaffer, A., Parikh, S. V., Beaulieu, S., O'Donovan, C., MacQueen, G., McIntyre, R. S., Sharma, V., Ravindran, A., et al. (2009) · Bipolar Disorders · doi:10.1111/j.1399-5618.2009.00672.x · Cited by 570
Self-citationThase, M. E., Macfadden, W., Weisler, R. H., Chang, W., Paulsson, B., Khan, A., & Calabrese, J. R. (2006) · Journal of Clinical Psychopharmacology · doi:10.1097/01.jcp.0000248603.76231.b7 · Cited by 559
Self-citationGlutamate and GABA systems as targets for novel antidepressant and mood-stabilizing treatments
Krystal, J. H., Sanacora, G., Blumberg, H., Anand, A., Charney, D. S., Marek, G., Epperson, C. N., Goddard, A., & Mason, G. F. (2002) · Molecular Psychiatry · doi:10.1038/sj.mp.4001021 · Cited by 553
Treatment and prevention of depression
Hollon, S. D., Thase, M. E., & Markowitz, J. C. (2002) · Psychological Science in the Public Interest · doi:10.1111/1529-1006.00008 · Cited by 511
Manji, H. K., Quiroz, J. A., Sporn, J., Payne, J. L., Denicoff, K., A. Gray, N., Zarate, C. A., & Charney, D. S. (2003) · Biological Psychiatry · doi:10.1016/s0006-3223(03)00117-3 · Cited by 505
The Stanley Foundation Bipolar Treatment Outcome Network
Suppes, T., Leverich, G. S., Keck, P. E., Nolen, W. A., Denicoff, K. D., Altshuler, L. L., McElroy, S. L., Rush, A. J., Kupka, R., Frye, M. A., et al. (2001) · Journal of Affective Disorders · doi:10.1016/s0165-0327(01)00432-3 · Cited by 484
Treatment Guidelines for Children and Adolescents With Bipolar Disorder
KOWATCH, R. A., FRISTAD, M., BIRMAHER, B., WAGNER, K. D., FINDLING, R. L., & HELLANDER, M. (2005) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/00004583-200503000-00006 · Cited by 455
A Review of Postpartum Psychosis
Sit, D., Rothschild, A. J., & Wisner, K. L. (2006) · Journal of Women's Health · doi:10.1089/jwh.2006.15.352 · Cited by 454
Goodwin, G., & Consensus Group of the British Association for Psychopharmacology (2009) · Journal of Psychopharmacology · doi:10.1177/0269881109102919 · Cited by 444
A Placebo-Controlled Study of Lamotrigine and Gabapentin Monotherapy in Refractory Mood Disorders
Frye, M. A., Ketter, T. A., Kimbrell, T. A., Dunn, R. T., Speer, A. M., Osuch, E. A., Luckenbaugh, D. A., Corá-Locatelli, G., Leverich, G. S., & Post, R. M. (2000) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-200012000-00004 · Cited by 446
Anand, A., Charney, D. S., Oren, D. A., Berman, R. M., Hu, X. S., Cappiello, A., & Krystal, J. H. (2000) · Archives of General Psychiatry · doi:10.1001/archpsyc.57.3.270 · Cited by 426
Leverich, G. S., Altshuler, L. L., Frye, M. A., Suppes, T., McElroy, S. L., Keck, P. E., Kupka, R. W., Denicoff, K. D., Nolen, W. A., Grunze, H., et al. (2006) · American Journal of Psychiatry · doi:10.1176/appi.ajp.163.2.232 · Cited by 419
Grunze, H., Vieta, E., Goodwin, G. M., Bowden, C., Licht, R. W., Möller, H.-J., Kasper, S., & WFSBP Task Force On Treatment Guidelines For Bipolar Disorders (2010) · The World Journal of Biological Psychiatry · doi:10.3109/15622970903555881 · Cited by 399
“Results from the fi rst double-blind, placebo-controlled clinical trial (Calabrese et al. 1999a) seemed to confi rm its effi cacy in bipolar depression at doses of 200 mg daily.”
BackgroundResultSelf-citationAntidepressants in bipolar disorder: the case for caution
Ghaemi, S. N., Hsu, D. J., Soldani, F., & Goodwin, F. K. (2003) · Bipolar Disorders · doi:10.1046/j.1399-5618.2003.00074.x · Cited by 393
The Expert Consensus Guideline Series: Medication Treatment of Bipolar Disorder 2000.
Sachs, G. S., PRINTZ, D. J., Kahn, D. A., Carpenter, D. P., & Docherty, J. P. (2000) · PubMed · Cited by 534
Self-citationYatham, L. N., Kennedy, S. H., O'Donovan, C., Parikh, S., MacQueen, G., McIntyre, R., Sharma, V., Silverstone, P., Alda, M., Baruch, P., et al. (2005) · Bipolar Disorders · doi:10.1111/j.1399-5618.2005.00219.x · Cited by 388
Goodwin, G. M. (2003) · Journal of Psychopharmacology · doi:10.1177/0269881103017002003 · Cited by 390
Müller-Oerlinghausen, B., Berghöfer, A., & Bauer, M. (2002) · The Lancet · doi:10.1016/s0140-6736(02)07450-0 · Cited by 331
An Open-Label Trial of Riluzole in Patients With Treatment-Resistant Major Depression
Zarate, C. A., Payne, J. L., Quiroz, J., Sporn, J., Denicoff, K. K., Luckenbaugh, D., Charney, D. S., & Manji, H. K. (2004) · American Journal of Psychiatry · doi:10.1176/appi.ajp.161.1.171 · Cited by 324
Suppes, T., Dennehy, E. B., Hirschfeld, R. M. A., Altshuler, L. L., Bowden, C. L., Calabrese, J. R., Crismon, M. L., Ketter, T. A., Sachs, G. S., Swann, A. C., et al. (2005) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v66n0710 · Cited by 330
Self-citationAntidepressant-Induced Sexual Dysfunction
Gregorian, R. S., Golden, K. A., Bahce, A., Goodman, C., Kwong, W. J., & Khan, Z. M. (2002) · Annals of Pharmacotherapy · doi:10.1345/aph.1a195 · Cited by 320
The comorbidity of bipolar and anxiety disorders: prevalence, psychobiology, and treatment issues
Freeman, M. P., Freeman, S. A., & McElroy, S. L. (2002) · Journal of Affective Disorders · doi:10.1016/s0165-0327(00)00299-8 · Cited by 304
Altshuler, L., Suppes, T., Black, D., Nolen, W. A., Keck, P. E., Frye, M. A., McElroy, S., Kupka, R., Grunze, H., Walden, J., et al. (2003) · American Journal of Psychiatry · doi:10.1176/appi.ajp.160.7.1252 · Cited by 287
Gender differences in bipolar disorder
Arnold, L. M. (2003) · Psychiatric Clinics of North America · doi:10.1016/s0193-953x(03)00036-4 · Cited by 272
Lamotrigine in spinal cord injury pain: a randomized controlled trial
Finnerup, N. B., Sindrup, S. H., Bach, F. W., Johannesen, I. L., & Jensen, T. S. (2002) · Pain · doi:10.1016/s0304-3959(01)00484-5 · Cited by 275
Cellular Plasticity Cascades: Targets for the Development of Novel Therapeutics for Bipolar Disorder
Zarate, C. A., Singh, J., & Manji, H. K. (2006) · Biological Psychiatry · doi:10.1016/j.biopsych.2005.10.021 · Cited by 274
Antidepressant Treatment in Bipolar Versus Unipolar Depression
Ghaemi, S. N., Rosenquist, K. J., Ko, J. Y., Baldassano, C. F., Kontos, N. J., & Baldessarini, R. J. (2004) · American Journal of Psychiatry · doi:10.1176/appi.ajp.161.1.163 · Cited by 270
Strategies to reduce misdiagnosis of bipolar depression
Bowden, C. L. (2001) · Psychiatric Services · doi:10.1176/appi.ps.52.1.51 · Cited by 267
Self-citationYatham, L. N., Kennedy, S. H., O'Donovan, C., Parikh, S. V., MacQueen, G., McIntyre, R. S., Sharma, V., Beaulieu, S., & for CANMAT guidelines group (2006) · Bipolar Disorders · doi:10.1111/j.1399-5618.2006.00432.x · Cited by 264
A Pilot Study of Mood in Epilepsy Patients Treated with Vagus Nerve Stimulation
Harden, C. L., Pulver, M. C., Ravdin, L. D., Nikolov, B., Halper, J. P., & Labar, D. R. (2000) · Epilepsy & Behavior · doi:10.1006/ebeh.2000.0046 · Cited by 250
Nierenberg, A. A., Ostacher, M. J., Calabrese, J. R., Ketter, T. A., Marangell, L. B., Miklowitz, D. J., Miyahara, S., Bauer, M. S., Thase, M. E., Wisniewski, S. R., et al. (2006) · American Journal of Psychiatry · doi:10.1176/appi.ajp.163.2.210 · Cited by 257
Self-citationCalabrese, J. R., Shelton, M. D., Rapport, D. J., Youngstrom, E. A., Jackson, K., Bilali, S., Ganocy, S. J., & Findling, R. L. (2005) · American Journal of Psychiatry · doi:10.1176/appi.ajp.162.11.2152 · Cited by 252
Self-citationThase, M. E., Jonas, A., Khan, A., Bowden, C. L., Wu, X., McQuade, R. D., Carson, W. H., Marcus, R. N., & Owen, R. (2008) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0b013e3181618eb4 · Cited by 251
Self-citationA Placebo-Controlled Evaluation of Adjunctive Modafinil in the Treatment of Bipolar Depression
Frye, M. A., Grunze, H., Suppes, T., McElroy, S. L., Keck, P. E., Walden, J., Leverich, G. S., Altshuler, L. L., Nakelsky, S., Hwang, S., et al. (2007) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2007.06060981 · Cited by 249
Calabrese, J. R., Huffman, R. F., White, R. L., Edwards, S., Thompson, T. R., Ascher, J. A., Monaghan, E. T., & Leadbetter, R. A. (2008) · Bipolar Disorders · doi:10.1111/j.1399-5618.2007.00500.x · Cited by 248
Self-citationNahas, Z., Kozel, F. A., Li, X., Anderson, B., & George, M. S. (2003) · Bipolar Disorders · doi:10.1034/j.1399-5618.2003.00011.x · Cited by 240
Glycogen synthase kinase‐3β, mood stabilizers, and neuroprotection
Li, X., Bijur, G. N., & Jope, R. S. (2002) · Bipolar Disorders · doi:10.1034/j.1399-5618.2002.40201.x · Cited by 243
Gould, T. D., Quiroz, J. A., Singh, J., Zarate, C. A., & Manji, H. K. (2004) · Molecular Psychiatry · doi:10.1038/sj.mp.4001518 · Cited by 238
Antiepileptic drugs: indications other than epilepsy
Spina, E., & Perugi, G. (2004) · Epileptic Disorders · doi:10.1684/j.1950-6945.2004.tb00053.x · Cited by 235
Voltage-gated sodium channels as therapeutic targets
Clare, J. J., Tate, S. N., Nobbs, M., & Romanos, M. A. (2000) · Drug Discovery Today · doi:10.1016/s1359-6446(00)01570-1 · Cited by 223
Increased Anterior Cingulate/Medial Prefrontal Cortical Glutamate and Creatine in Bipolar Depression
Frye, M. A., Watzl, J., Banakar, S., O'Neill, J., Mintz, J., Davanzo, P., Fischer, J., Chirichigno, J. W., Ventura, J., Elman, S., et al. (2007) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301387 · Cited by 222
Review of the Use of Topiramate for Treatment of Bipolar Disorders
Suppes, T. (2002) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-200212000-00010 · Cited by 215
Du, J., Suzuki, K., Wei, Y., Wang, Y., Blumenthal, R., Chen, Z., Falke, C., Zarate, C. A., & Manji, H. K. (2007) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301178 · Cited by 208
Open-label adjunctive topiramate in the treatment of bipolar disorders
McElroy, S. L., Suppes, T., Keck, P. E., Frye, M. A., Denicoff, K. D., Altshuler, L. L., Brown, E. S., Nolen, W. A., Kupka, R. W., Rochussen, J., et al. (2000) · Biological Psychiatry · doi:10.1016/s0006-3223(99)00316-9 · Cited by 210
A different depression: clinical distinctions between bipolar and unipolar depression
Bowden, C. L. (2005) · Journal of Affective Disorders · doi:10.1016/s0165-0327(03)00194-0 · Cited by 207
Self-citationRendleman, R., & Walkup, J. T. (2012) · Swaiman's Pediatric Neurology · doi:10.1016/b978-1-4377-0435-8.00049-4 · Cited by 196
The Psychopathology and Treatment of Bipolar Disorder
Miklowitz, D. J., & Johnson, S. L. (2006) · Annual Review of Clinical Psychology · doi:10.1146/annurev.clinpsy.2.022305.095332 · Cited by 180
Newer Antiepileptic Drugs in Bipolar Disorder: Rationale for Use and Role in Therapy
Macdonald, K. J., & Young, L. T. (2002) · CNS Drugs · doi:10.2165/00023210-200216080-00004 · Cited by 189
The Stanley Foundation Bipolar Treatment Outcome Network
Leverich, G. S., Nolen, W. A., Rush, A. J., McElroy, S. L., Keck, P. E., Denicoff, K. D., Suppes, T., Altshuler, L. L., Kupka, R., Kramlinger, K. G., et al. (2001) · Journal of Affective Disorders · doi:10.1016/s0165-0327(01)00430-x · Cited by 185
Grunze, H., Kasper, S., Goodwin, G., Bowden, C., Baldwin, D., Licht, R., Vieta, E., Möller, H.-J., & WFSBP Task Force on Treatment Guide (2002) · The World Journal of Biological Psychiatry · doi:10.3109/15622970209150612 · Cited by 185
Self-citationTreatment-resistant bipolar disorder
Gitlin, M. (2006) · Molecular Psychiatry · doi:10.1038/sj.mp.4001793 · Cited by 184
CHANG, K., SAXENA, K., & HOWE, M. (2006) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/01.chi.0000194566.86160.a3 · Cited by 182
“There are data to support the use of lamotrigine in adults with rapid cycling BD (Calabrese et al., 1999a).”
BackgroundResultDivalproex in the treatment of bipolar depression: a placebo-controlled study
Davis, L. L., Bartolucci, A., & Petty, F. (2005) · Journal of Affective Disorders · doi:10.1016/j.jad.2004.09.009 · Cited by 181
Green, B. (2003) · Current Medical Research and Opinion · doi:10.1185/030079903125001703 · Cited by 179
Clinical consequences of under‐recognized bipolar spectrum disorder
Dunner, D. L. (2003) · Bipolar Disorders · doi:10.1046/j.1399-5618.2003.00073.x · Cited by 178
Kushner, S. F., Khan, A., Lane, R., & Olson, W. H. (2006) · Bipolar Disorders · doi:10.1111/j.1399-5618.2006.00276.x · Cited by 180
Zink, M., Vollmayr, B., Gebicke-Haerter, P. J., & Henn, F. A. (2010) · Neuropharmacology · doi:10.1016/j.neuropharm.2009.09.005 · Cited by 177
Treatment of bipolar disorder: a systematic review of available data and clinical perspectives
Fountoulakis, K. N., & Vieta, E. (2008) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145708009231 · Cited by 169
Why are antiepileptic drugs used for nonepileptic conditions?
Bialer, M. (2012) · Epilepsia · doi:10.1111/j.1528-1167.2012.03712.x · Cited by 174
Weight gain in bipolar disorder: pharmacological treatment as a contributing factor
Torrent, C., Amann, B., Sánchez‐Moreno, J., Colom, F., Reinares, M., Comes, M., Rosa, A. R., Scott, J., & Vieta, E. (2008) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.2008.01204.x · Cited by 169
Lamotrigine: A Review of its Use in Bipolar Disorder
Goldsmith, D. R., Wagstaff, A. J., Ibbotson, T., & Perry, C. M. (2003) · Drugs · doi:10.2165/00003495-200363190-00009 · Cited by 171
McIntyre, R. S., Mancini, D. A., McCann, S., Srinivasan, J., Sagman, D., & Kennedy, S. H. (2002) · Bipolar Disorders · doi:10.1034/j.1399-5618.2002.01189.x · Cited by 174
Bipolar Disorder — A Focus on Depression
Frye, M. A. (2011) · New England Journal of Medicine · doi:10.1056/nejmcp1000402 · Cited by 170
Molecular targets in the treatment of anxiety
Kent, J. M., Mathew, S. J., & Gorman, J. M. (2002) · Biological Psychiatry · doi:10.1016/s0006-3223(02)01672-4 · Cited by 167
ZARATE, C. A., DU, J., QUIROZ, J., GRAY, N. A., DENICOFF, K. D., SINGH, J., CHARNEY, D. S., & MANJI, H. K. (2003) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1300.017 · Cited by 164
Differential cognitive and behavioral effects of carbamazepine and lamotrigine
Meador, K. J., Loring, D. W., Ray, P. G., Murro, A. M., King, D. W., Perrine, K. R., Vazquez, B. R., & Kiolbasa, T. (2001) · Neurology · doi:10.1212/wnl.56.9.1177 · Cited by 166
Bipolar Depression: Overview and Commentary
Baldessarini, R. J., Vieta, E., Calabrese, J. R., Tohen, M., & Bowden, C. L. (2010) · Harvard Review of Psychiatry · doi:10.3109/10673221003747955 · Cited by 156
Self-citationPrevalence of bipolar symptoms in epilepsy vs other chronic health disorders
Ettinger, A. B., Reed, M. L., Goldberg, J. F., & Hirschfeld, R. M. A. (2005) · Neurology · doi:10.1212/01.wnl.0000172917.70752.05 · Cited by 158
Bipolar disorder and mechanisms of action of mood stabilizers
Rapoport, S. I., Basselin, M., Kim, H.-W., & Rao, J. S. (2009) · Brain Research Reviews · doi:10.1016/j.brainresrev.2009.06.003 · Cited by 155
The co-morbidity of depression and epilepsy: Epidemiology, etiology, and treatment
Harden, C. L. (2002) · Neurology · doi:10.1212/wnl.59.6_suppl_4.s48 · Cited by 159
Pharmacologic agents for the treatment of acute bipolar mania
McElroy, S. L., & Keck, P. E. (2000) · Biological Psychiatry · doi:10.1016/s0006-3223(00)00961-6 · Cited by 160
Open-Label Lithium for the Treatment of Adolescents With Bipolar Depression
PATEL, N. C., DELBELLO, M. P., BRYAN, H. S., ADLER, C. M., KOWATCH, R. A., STANFORD, K., & STRAKOWSKI, S. M. (2006) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/01.chi.0000194569.70912.a7 · Cited by 157
A History of the Pharmacological Treatment of Bipolar Disorder
Lopez-Munoz, F. J., Shen, W., D’Ocón, P., Romero, A., & Álamo, C. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19072143 · Cited by 168
Use of antiepileptic drugs for nonepileptic conditions: Psychiatric disorders and chronic pain
Ettinger, A., & Argoff, C. (2011) · Neurotherapeutics · doi:10.1016/j.nurt.2006.10.003 · Cited by 154
Neural circuitry and neuroplasticity in mood disorders: Insights for novel therapeutic targets
Carlson, P. J., Singh, J. B., Zarate, C. A., Drevets, W. C., & Manji, H. K. (2006) · NeuroRx · doi:10.1016/j.nurx.2005.12.009 · Cited by 177
Mood Disorders in Patients with Epilepsy: Epidemiology and Management
Harden, C. L., & Goldstein, M. A. (2002) · CNS Drugs · doi:10.2165/00023210-200216050-00002 · Cited by 159
Grunze, H. (2011) · FOCUS: The Journal of Lifelong Learning in Psychiatry · doi:10.1176/appi.focus.9.4.500 · Cited by 149
Self-citationECNP consensus meeting. Bipolar depression. Nice, March 2007
Goodwin, G. M., Anderson, I. M., Arango, C., Bowden, C. L., Henry, C., Mitchell, P. B., Nolen, W. A., Vieta, E., & Wïttchen, H. (2008) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2008.03.003 · Cited by 170
Self-citationXia, G., Gajwani, P., Muzina, D. J., Kemp, D. E., Gao, K., Ganocy, S. J., & Calabrese, J. R. (2008) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145707007699 · Cited by 149
Self-citationProgress report on new antiepileptic drugs: a summary of the Fifth Eilat Conference (EILAT V)
Bialer, M., Johannessen, S. I., Kupferberg, H. J., Levy, R. H., Loiseau, P., & Perucca, E. (2001) · Epilepsy Research · doi:10.1016/s0920-1211(00)00171-6 · Cited by 152
Bipolar II Disorder: Epidemiology, Diagnosis and Management
Benazzi, F. (2007) · CNS Drugs · doi:10.2165/00023210-200721090-00003 · Cited by 175
Okamoto, N., Nakai, T., Sakamoto, K., Nagafusa, Y., Higuchi, T., & Nishikawa, T. (2010) · The Journal of ECT · doi:10.1097/yct.0b013e3181c3b0aa · Cited by 149
Psychotropic effects of antiepileptic drugs
Ettinger, A. B. (2006) · Neurology · doi:10.1212/01.wnl.0000247045.85646.c0 · Cited by 148
Bipolar depression: pharmacotherapy and related therapeutic strategies
Thase, M. E., & Sachs, G. S. (2000) · Biological Psychiatry · doi:10.1016/s0006-3223(00)00980-x · Cited by 158
Self-citationGrunze, H., Kasper, S., Goodwin, G., Bowden, C., Mo¨ller, H.-J., & WFSBP Task Force on Treatment Guide (2004) · The World Journal of Biological Psychiatry · doi:10.1080/15622970410029924 · Cited by 144
Self-citationAgitation, aggression, and disinhibition syndromes after traumatic brain injury
Kim, E. (2002) · NeuroRehabilitation · doi:10.3233/nre-2002-17404 · Cited by 144
Post, R. M., Leverich, G. S., Nolen, W. A., Kupka, R. W., Altshuler, L. L., Frye, M. A., Suppes, T., McElroy, S., Keck, P., Grunze, H., et al. (2003) · Bipolar Disorders · doi:10.1046/j.1399-5618.2003.00065.x · Cited by 142
Metadata
- Authors
- Calabrese, J. R., Bowden, C. L., Sachs, G. S., Ascher, J. A., Monaghan, E., Rudd, G. D., & The Lamictal 602 Study Group
- Affiliations
- Case Western Reserve University (US)
- GlaxoSmithKline (United Kingdom) (GB)
- ORCID
- Calabrese, Joseph R.
- Venue
- The Journal of Clinical Psychiatry
- Publisher
- Physicians Postgraduate Press, Inc
- Published
- 1999-02-15
- Volume
- 60
- Issue
- 2
- Pages
- 79-88
- ISSN
- 0160-6689 (ISSN-L)
- OpenAlex
- W2058120764
- Cited by
- 1,054
- References
- 0
- Citations by year
- 2026: 5 · 2025: 6 · 2024: 15 · 2023: 8 · 2022: 8 · 2021: 7 · 2020: 162 · 2019: 10 · 2018: 13 · 2017: 13 · 2016: 13 · 2015: 18 · 2014: 23 · 2013: 24 · 2012: 34
- FWCI
- 47.99
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The Journal of Clinical Psychiatry (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Bipolar Disorder and Treatment
- Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Maternal Mental Health During Pregnancy and Postpartum
- Keywords
- lamotrigine, bipolar I depression, bipolar disorder, antidepressant monotherapy, antiepileptic drugs, major depressive episode, treatment response, adverse events, headache, drug tolerability
- MeSH terms
- Lamotrigine, Adult, Aged, Ambulatory Care, Anticonvulsants, Bipolar Disorder, Depressive Disorder, Dose-Response Relationship, Drug, Double-Blind Method, Drug Administration Schedule, Female, Humans, Male, Middle Aged, Patient Compliance, Placebos, Psychiatric Status Rating Scales, Severity of Illness Index, Triazines, Treatment Outcome
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.